Deutsche Bank’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,700
| Closed | -$25.5K | – | 3812 |
|
|
2023
Q3 | $25.5K | Hold |
1,700
| – | – | ﹤0.01% | 3495 |
|
|
2023
Q2 | $22.1K | Hold |
1,700
| – | – | ﹤0.01% | 3570 |
|
|
2023
Q1 | $19.9K | Hold |
1,700
| – | – | ﹤0.01% | 3720 |
|
|
2022
Q4 | $26.1K | Buy |
+1,700
| New | +$19.8K | ﹤0.01% | 3730 |
|
|
2020
Q3 | – | Sell |
-26
| Closed | -$3K | – | 4483 |
|
|
2020
Q2 | $3K | Sell |
26
-91
| -78% | -$9.62K | ﹤0.01% | 4182 |
|
|
2020
Q1 | $13K | Sell |
117
-7
| -6% | -$1.38K | ﹤0.01% | 4013 |
|
|
2019
Q4 | $30K | Sell |
124
-1,200
| -91% | -$303K | ﹤0.01% | 4168 |
|
|
2019
Q3 | $455K | Sell |
1,324
-4,131
| -76% | -$2.25M | ﹤0.01% | 2723 |
|
|
2019
Q2 | $5.02M | Buy |
5,455
+900
| +20% | +$1.11M | ﹤0.01% | 1807 |
|
|
2019
Q1 | $7.26M | Buy |
4,555
+1,883
| +70% | +$3.39M | ﹤0.01% | 1588 |
|
|
2018
Q4 | $4.99M | Sell |
2,672
-2,213
| -45% | -$4.82M | ﹤0.01% | 1773 |
|
|
2018
Q3 | $11.5M | Buy |
4,885
+2,692
| +123% | +$8.33M | 0.01% | 1531 |
|
|
2018
Q2 | $7.55M | Sell |
2,193
-335
| -13% | -$1.03M | ﹤0.01% | 1972 |
|
|
2018
Q1 | $7.17M | Buy |
2,528
+1,188
| +89% | +$3.56M | ﹤0.01% | 1913 |
|
|
2017
Q4 | $3.45M | Sell |
1,340
-4,297
| -76% | -$12.2M | ﹤0.01% | 2337 |
|
|
2017
Q3 | $16M | Buy |
5,637
+3,588
| +175% | +$9.45M | 0.01% | 1163 |
|
|
2017
Q2 | $4.84M | Buy |
2,049
+317
| +18% | +$628K | ﹤0.01% | 1947 |
|
|
2017
Q1 | $4.36M | Buy |
1,732
+130
| +8% | +$374K | ﹤0.01% | 1756 |
|
|
2016
Q4 | $3.61M | Buy |
1,602
+427
| +36% | +$1.02M | ﹤0.01% | 1868 |
|
|
2016
Q3 | $2.94M | Sell |
1,175
-633
| -35% | -$1.89M | ﹤0.01% | 2095 |
|
|
2016
Q2 | $5.53M | Buy |
1,808
+623
| +53% | +$2.03M | ﹤0.01% | 1681 |
|
|
2016
Q1 | $3.76M | Sell |
1,185
-190
| -14% | -$789K | ﹤0.01% | 1947 |
|
|
2015
Q4 | $7.06M | Buy |
1,375
+673
| +96% | +$2.94M | ﹤0.01% | 1548 |
|
|
2015
Q3 | $2.23M | Sell |
702
-328
| -32% | -$1.27M | ﹤0.01% | 2412 |
|
|
2015
Q2 | $4.12M | Sell |
1,030
-201
| -16% | -$776K | ﹤0.01% | 1931 |
|
|
2015
Q1 | $4.92M | Buy |
1,231
+776
| +171% | +$3.55M | ﹤0.01% | 1796 |
|
|
2014
Q4 | $2.23M | Sell |
455
-217
| -32% | -$931K | ﹤0.01% | 2599 |
|
|
2014
Q3 | $2.73M | Sell |
672
-376
| -36% | -$1.41M | ﹤0.01% | 2286 |
|
|
2014
Q2 | $4.23M | Buy |
1,048
+211
| +25% | +$860K | ﹤0.01% | 1934 |
|
|
2014
Q1 | $3.81M | Sell |
837
-62
| -7% | -$251K | ﹤0.01% | 2007 |
|
|
2013
Q4 | $3.15M | Buy |
899
+286
| +47% | +$1.12M | ﹤0.01% | 2033 |
|
|
2013
Q3 | $2.51M | Sell |
613
-2,527
| -80% | -$10.9M | ﹤0.01% | 2323 |
|
|
2013
Q2 | $12.4M | Buy |
+3,140
| New | +$12.9M | 0.01% | 1112 |
|
Other funds holding ACOR
DKCM
Deutsche Bank's ACOR Position: Q4 2023 in Review
Deutsche Bank sold out of Acorda Therapeutics (ACOR) in Q4 2023, closing a stake of 1,700 shares — an estimated $25.5K sold.
Deutsche Bank first reported a position in ACOR in Q2 2013 and held it in 33 quarters. The position peaked at $16M in Q3 2017. 15 funds tracked by Wall St. Rank hold ACOR as of Q4 2023.
- Deutsche Bank reported no remaining Acorda Therapeutics position as of Q4 2023 after selling out during the quarter.
- Deutsche Bank sold 1,700 Acorda Therapeutics shares in Q4 2023, an estimated $25.5K.
- Deutsche Bank first reported a position in Acorda Therapeutics in Q2 2013 and held it in 33 quarters.
- Deutsche Bank's Acorda Therapeutics position peaked at $16M in Q3 2017.
- 15 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2023.
Based on Deutsche Bank's 13F filing for Q4 2023, filed 14 Feb 2024.